Pharmacokinetics of nevirapine: initial single-rising-dose study in humans.

Nevirapine, a nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase, was administered for the first time to humans in a pilot study designed to investigate the pharmacokinetics and tolerance of the drug following single-dose administration to 21 HIV-1-infected...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Cheeseman, S H, Hattox, S E, McLaughlin, M M, Koup, R A, Andrews, C, Bova, C A, Pav, J W, Roy, T, Sullivan, J L, Keirns, J J
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1993
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187634/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8452345/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.2.178
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!